LearnDrugs.com
Nervous

Atypical Antidepressants

Verified · Jul 2026

Prototype: bupropion

A grab-bag of antidepressants that don’t fit the SSRI/SNRI/TCA/MAOI molds — each chosen for its distinctive profile.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 Different mechanisms, chosen for their side effects

These agents are grouped by exclusion — they’re the antidepressants that aren’t SSRIs, SNRIs, TCAs, or MAOIs. In practice each is picked precisely because of its distinctive side-effect profile, matched to the patient.

Bupropion raises dopamine and norepinephrine (not serotonin): it is activating, causes no sexual dysfunction or weight gain (often added to counter SSRI sexual side effects), and doubles as a smoking-cessation aid — but it lowers the seizure threshold. Mirtazapine is sedating and increases appetite, making it useful for a depressed patient with insomnia and weight loss. Trazodone is so sedating that it is used mostly in low doses as a sleep aid.

Each atypical is matched to a patient by its signature effect.

02 The safety flags to remember

For bupropion, the key rule is the seizure risk: it is contraindicated in seizure disorders and in eating disorders (bulimia/anorexia) and in patients undergoing abrupt alcohol/benzodiazepine withdrawal, all of which further lower the seizure threshold. For trazodone, teach the rare but urgent priapism (a painful erection > 4 hours is an emergency). All carry the antidepressant class boxed warning for suicidality, and all can contribute to serotonin syndrome when combined with other serotonergic drugs.

Drug names

Generic Brand
bupropion Wellbutrin, Zyban
mirtazapine Remeron
trazodone Desyrel

Indications

  • Major depression (all); SSRI-augmentation for sexual side effects (bupropion)
  • Smoking cessation (bupropion/Zyban); seasonal affective disorder
  • Depression with insomnia/weight loss (mirtazapine); insomnia (low-dose trazodone)

Mechanism of action

Bupropion inhibits dopamine and norepinephrine reuptake (norepinephrine-dopamine reuptake inhibitor). Mirtazapine is a noradrenergic/specific-serotonergic agent (α2 antagonist; H1 blockade → sedation/appetite). Trazodone is a serotonin antagonist/reuptake inhibitor (strong H1/α1 blockade → sedation).

In plain terms
A mixed bag: bupropion energizes (dopamine/norepinephrine), while mirtazapine and trazodone calm and aid sleep.

Therapeutic effects — what you'll see working

Choose the agent by the patient: bupropion for low energy/sexual side effects/smoking; mirtazapine for insomnia with poor appetite; trazodone for sleep. Mood benefit takes weeks; sedation/appetite effects are immediate.

Antidepressant effect Targeted secondary benefits
Antidepressant effect
All relieve depression over weeks through their respective monoamine actions.
Targeted secondary benefits
Bupropion: activation, smoking cessation, no sexual dysfunction. Mirtazapine: improved sleep and appetite. Trazodone: sleep.

Adverse effects

Each agent’s "benefit" (activation or sedation) is also its main adverse-effect theme; the standout safety flags are bupropion’s seizures and trazodone’s priapism.

Caution: Common
Bupropion: insomnia, dry mouth, agitation, decreased appetite. Mirtazapine: sedation, weight gain. Trazodone: sedation, orthostatic hypotension, dizziness.
The activating vs sedating split is the practical fingerprint of each drug.
Warning: Serious Report immediately
Bupropion: seizures (dose-related). Trazodone: priapism (urologic emergency), orthostatic syncope. Serotonin syndrome with serotonergic combinations.
Bupropion lowers the seizure threshold — contraindicated in seizure/eating disorders. Trazodone priapism (erection > 4 h) requires emergency care to prevent permanent damage.
Black-box warning — most severe: ■ Boxed warning · suicidality
Increased suicidal thinking/behavior in patients < 25 early in treatment.
The antidepressant class warning applies to all three.

Contraindications

The contraindications are agent-specific — chiefly the seizure-threshold rule for bupropion.

Seizure disorder; bulimia/anorexia; abrupt alcohol/benzodiazepine withdrawal (bupropion)
Bupropion lowers the seizure threshold; these states compound the risk of seizures.
Concurrent MAOIs (all) or within 14 days
Risk of hypertensive crisis / serotonin syndrome.
Predisposition to priapism (trazodone) use caution
Trazodone can cause priapism, a urologic emergency.

When to hold

Assess before giving — these findings mean hold the dose and act.

Seizure disorder, or eating disorder (bulimia/anorexia) — bupropion
Bupropion lowers the seizure threshold — avoid; these states (and abrupt alcohol/benzodiazepine withdrawal) further lower it and compound seizure risk.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Agent-specific safety
Screen for seizure history and eating disorders before bupropion; give the second dose early to limit insomnia.
Why: Bupropion is contraindicated where the seizure threshold is already low; it is activating.
Teach trazodone patients that a prolonged/painful erection (> 4 h) is an emergency; use its sedation at bedtime.
Why: Priapism can cause permanent damage; the sedation is leveraged for sleep.
Patient teaching
Expect 2–4 weeks for mood benefit; report worsening mood or suicidality; do not combine with MAOIs.
Why: Delayed onset, the boxed warning, and interaction risk apply across the group.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.